SCHEMBL7765007

SCHEMBL7765007

CC(C)(S)C1CC(CS)C(=O)O1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 2/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7767464 1.00 TP53 (0.32) TP53KMT2AATMKDM4E
SCHEMBL7765794 0.82
SCHEMBL7767486 0.70 POLB (0.37) KMT2A
SCHEMBL9033045 0.70 POLB (0.37) KMT2A
SCHEMBL9033654 0.70 POLB (0.37) KMT2A
SCHEMBL7764890 0.69
SCHEMBL7769363 0.66 ACE (0.31)
SCHEMBL7767455 0.65 KMT2A (0.36) KMT2AKDM4E
SCHEMBL7767499 0.63 POLB (0.31)
SCHEMBL7769357 0.63 ALDH1A1 (0.37) KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5461158-A Immunodeficiency and autoimmune diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US claimed
EP-0639566-B1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO LTD (JP) 2001-06-20 EP disclosed
US-5461158-A Immunodeficiency and autoimmune diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US disclosed
EP-0639566-A1 CYCLIC COMPOUND SANTEN PHARMACEUTICAL CO., LTD. (JP) 1995-02-22 EP disclosed